![Hydroxocobalamin antidote](https://cdn1.cdnme.se/5447227/9-3/screenshot_5_64e62947ddf2b306ca76f796.jpg)
![hydroxocobalamin antidote hydroxocobalamin antidote](https://www.baymed.co.uk/wp-content/uploads/2016/06/Hydroxocobalamin.png)
Note: Continue parenteral therapy until the deficiency has been corrected and signs and symptoms have resolved before switching to oral therapy (Means 2021).
![hydroxocobalamin antidote hydroxocobalamin antidote](https://cdn.shopify.com/s/files/1/1836/2355/products/MTHFR_Group_Hydroxocobalamin_B12_Powder_75g_Media-01_700x700.jpg)
Alternatively, if neurologic symptoms are present, may initiate 1,000 mcg every other day for up to 3 weeks or until no further improvement in signs or symptoms, then switch to 1,000 mcg once weekly for up to 12 weeks (Devalia 2014 Means 2021). Initial therapy: IM: 1,000 mcg every other day or once daily for 1 to 2 weeks, then 1,000 mcg once weekly for 4 to 8 weeks (Devalia 2014 Mechanick 2020 Stabler 2013). Severe/symptomatic anemia or neurologic/neuropsychiatric findings:
![hydroxocobalamin antidote hydroxocobalamin antidote](https://cached.imagescaler.hbpl.co.uk/resize/scaleWidth/620/cached.offlinehbpl.hbpl.co.uk/news/2MM/679AA68A-E4FC-53CC-2DE58DCA0B05F36A.jpg)
Oral vitamin B 12 (eg, cyanocobalamin) may be used for less severe deficiency and/or maintenance therapy (Devalia 2014). Note: Folic acid supplementation may also be required.
![Hydroxocobalamin antidote](https://cdn1.cdnme.se/5447227/9-3/screenshot_5_64e62947ddf2b306ca76f796.jpg)